Otonomy Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Back to Jobs

Results from three clinical trials expected in 2020 including the Phase 3 trial of OTIVIDEX™  in Ménière’s disease Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. ET SAN DIEGO , Feb. 27, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a

Apply Now